Back Login for AI Analysis

    GNPX (STOCKS)

    Genprex, Inc. Common Stock

    $2.060000
    +0.020000 (+0.98%)
    Prev close: $2.040000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Ryan M. Confer
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $4.64M
    Employees
    15
    P/E (TTM)
    -0.04
    P/B (TTM)
    2.67
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Sep 2025)
    Revenues $0.00
    Costs And Expenses $16.33M
    Research and Development $10.07M
    Operating Income/Loss -$16.33M
    Income/Loss From Continuing Operations After Tax -$16.77M
    Income/Loss From Continuing Operations Before Tax -$16.32M
    Net Income/Loss -$16.77M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$16.77M
    Net Income/Loss Available To Common Stockholders, Basic -$16.77M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share $316.58
    Basic Average Shares 4,498,253
    Assets $3.56M
    Current Assets $1.72M
    Noncurrent Assets $1.85M
    Liabilities $2.79M
    Current Liabilities $2.55M
    Noncurrent Liabilities $243.00K
    Equity $767.81K
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $767.81K
    Liabilities And Equity $3.56M
    Net Cash Flow From Operating Activities -$14.31M
    Net Cash Flow From Operating Activities, Continuing -$14.31M
    Net Cash Flow From Investing Activities -$275.13K
    Net Cash Flow From Investing Activities, Continuing -$275.13K
    Net Cash Flow From Financing Activities $14.70M
    Net Cash Flow From Financing Activities, Continuing $14.70M
    Net Cash Flow $113.38K
    Net Cash Flow, Continuing $113.38K
    Comprehensive Income/Loss -$16.77M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$16.77M
    Other Comprehensive Income/Loss $0.00